Abstract
Introduction: Cerebral hypoperfusion has been considered as major risk factor for Vascular Dementia (VaD). The present study shows the potential of Tadalafil, a phosphodiesterase-5 inhibitor, in bilateral common carotid artery occlusion (BCCAo) induced VaD in rats.
Materials and Methods: BCCAo procedure was performed under anesthesia in wistar rats to induce VaD. Morris Water-Maze (MWM) parameter was employed on 7th day post-surgery to determine learning and memory. Escape latency time, time spent in target quadrant, Path length and average swim speed taken as important parameters in MWM. Endothelial dysfunction was assessed in isolated aorta by observing endothelial dependent vasorelaxations and levels of serum nitrite. Various biochemical and histopathological estimations were also performed.
Results: BCCAo produced significant impairment in endothelium dependent vasorelaxation and a decrease in serum nitrite levels indicating endothelial dysfunction. Further poor performance on MWM represents impairment of learning and memory. There was a significant rise in brain oxidative stress level (indicated by increase in brain thiobarbituric acid reactive species and decrease in reduced glutathione levels). Increase in brain acetylcholinesterase activity; brain myloperoxidase activity and brain neutrophil infiltration (as marker of inflammation) were also observed. Treatment of Tadalafil (5 & 10 mg/kg, p. o.)/Donepezil (0. 5 mg/kg, i.p., serving as standard) ameliorated BCCAo induced endothelial dysfunction; memory deficits; biochemical and histopathological changes in a significant manner.
Conclusion: It may be concluded that Tadalafil has shown efficacy in rat model of BCCAo induced VaD and that phosphodiesterase-5 can be considered as an important therapeutic target for the treatment of VaD.
Keywords: Phosphodieseterase-5, tadalafil, oxidative stress, memory, vascular dementia, cerebral hemodynamic.
[1]
Lockhart BP, Lestage PJ. Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: Why? when? which? Exp Gerontol 2003; 38(1-2): 119-28.
[2]
Weintraub S, Wicklund AH, Salmon DP. The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2(4): 1-18.
[3]
Perera G, Stewart R, Higginson IJ, Sleeman KE. Reporting of clinically diagnosed dementia on death certificates: Retrospective cohort study. Age Ageing 2016; 45(5): 668-73.
[4]
Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42(9): 2672-713.
[5]
Toledo JB, Arnold SE, Raible K, et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre. Brain 2013; 136(9): 2697-706.
[6]
Murphy MP, Corriveau RA, Wilcock DM. Vascular contributions to cognitive impairment and dementia (VCID). Biochim Biophys Acta 2016; 5(1862): 857-9.
[7]
Sheng M, Lu H, Liu P, et al. Sildenafil improves vascular and metabolic functions in patients with Alzheimer’s Disease. J Alzheimers Dis 2017; 60(4): 1351-64.
[8]
Lu C, Dun L, Liu G, et al. Neuroprotective and anti-dementia role of Tongqiao Huoxue decoction in rats with vascular dementia. Int J Clin Exp Med 2016; 9(2): 3197-202.
[9]
Jiwa NS, Garrard P, Hainsworth AH. Experimental models of vascular dementia and vascular cognitive impairment: A systematic review. J Neurochem 2010; 115(4): 814-28.
[10]
Gooch J, Wilcock DM. Animal Models of Vascular Cognitive Impairment and Dementia (VCID). Mol Neurobiol 2016; 36(2): 233-9.
[11]
Marshall RS. Effects of altered cerebral hemodynamics on cognitive function. J Alzheimers Dis 2012; 32(3): 633-42.
[12]
Peters R. Blood pressure, smoking and alcohol use, association with vascular dementia. Exp Gerontol 2012; 47(11): 865-72.
[13]
Cao Y, Liang L, Xu J, Wu J, et al. The effect of Scutellaria baicalensis stem-leaf flavonoids on spatial learning and memory in chronic cerebral ischemia-induced vascular dementia of rats. Acta Biochim Biophys Sin 2016; 48(5): 437-46.
[14]
Erkinjuntti T, Román G, Gauthier S, et al. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 2004; 35(4): 1010-7.
[15]
Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006; 58(3): 488-520.
[16]
Martinez A, Gil C. cAMP-specific phosphodiesterase inhibitors:
promising drugs for inflammatory and neurological diseases. Expert opinion on therapeutic patents 2014; 24(12): 1311-21.
[17]
Harrison SA, Reifsnyder DH, Gallis BY, Cadd GG, Beavo JA. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Mol Pharmacol 1986; 29(5): 506-14.
[18]
Tanaka T, Ishikawa T, Hagiwara M, Onoda K, Itoh H, Hidaka H. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology 1988; 36(5): 313-20.
[19]
Padma-Nathan H, McMurray JG, Pullman WE, et al. On-demand IC351 (Cialis™) enhances erectile function in patients with erectile dysfunction. Int J Impot Res 2001; 13(1): 2-9.
[20]
Ölmestig JN, Marlet IR, Hainsworth AH, Kruuse C. Phosphodiesterase 5 inhibition as a therapeutic target for ischemic stroke: A systematic review of preclinical studies. Cell Signal 2017; 38: 39-48.
[21]
Schwartz BG, Jackson G, Stecher VJ, Campoli-Richards DM, Kloner RA. Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditions. Am J Med 2013; 126(3): 192-9.
[22]
Titus DJ, Oliva AA, Wilson NM, Atkins CM. Phosphodiesterase inhibitors as therapeutics for traumatic brain injury. Curr Pharm Des 2015; 21(3): 332-42.
[23]
Gulati P, Singh N. Neuroprotective effect of tadalafil, a PDE-5 inhibitor, and its modulation by L-NAME in mouse model of ischemia-reperfusion injury. J Surg Res 2014; 186(1): 475-83.
[24]
Sharma B, Singh N. Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats. Psychopharmacology 2011; 215(4): 677-87.
[25]
Muthuraman A, Singh N. Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: An evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement Altern Med 2011; 11: 24.
[26]
Nandagopal M, Muralidharan P, Thirumurugan G. Behavioral assessment studies in cerebral ischemia induced by bilateral carotid artery occlusion in rats. Ann Biol Res 2010; 1: 208-23.
[27]
Kaur J, Sharma S, Sandhu M, Sharma S. Neurokinin-1 receptor inhibition reverses ischaemic brain injury and dementia in bilateral common carotid artery occluded rats: Possible mechanisms. Inflammopharmacology 2016; 24(4): 133-43.
[28]
Feng J, Fitz Y, Li Y, et al. Catheterization of the carotid artery and jugular vein to perform hemodynamic measures, infusions and blood sampling in a conscious rat model. J Vis Exp 2015; 95: 1-6.
[29]
Wang H. Establishment of an animal model of vascular dementia. Exp Ther Med 2014; 8(5): 1599-603.
[30]
Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11(1): 47-60.
[31]
Parle M, Singh N. Reversal of memory deficits by atorvastatin and simvastatin in rats. Yakugaku Zasshi 2007; 127(7): 1125-37.
[32]
Pieper GM. Diabetic induced endothelial dysfunction in rat aorta: Role of hydroxyl radicals. Cardiovasc Res 1997; 34: 145-56.
[33]
Sharma B, Singh N. Pitavastatin and 4′-hydroxy-3′-methoxy-acetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes. Curr Neurovasc Res 2010; 7: 180-91.
[34]
Teixeira CE, Priviero FB, Webb RC. Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta. J Pharmacol Exp Ther 2006; 316(2): 654-61.
[35]
Koladiya RU, Jaggi AS, Singh N, Sharma BK. Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats. BMC Pharmacol 2008; 8(1): 14.
[36]
Ellman GL, Courtney KD, Andres V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
[37]
Grisham MB, Benoit JN, Granger DN. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 1990; 186: 729-42.
[38]
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95(2): 351-8.
[39]
Boyne AF, Ellman GL. A methodology for analysis of tissue sulfhydryl components. Anal Biochem 1972; 46(2): 639-53.
[40]
Sastry K, Moudgal R, Mohan J, et al. Spectrophotometric determination of serum nitrite and nitrate by copper–cadmium alloy. Anal Biochem 2002; 306(1): 79-82.
[41]
Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193(1): 265-75.
[42]
Banchroft AS, Turner DR. Theory and Practice of Histological
Techniques. 4th ed. Churchil livingstone, New York: Wiley-Liss. 1996.
[43]
Camarasa J, Rodrigo T, Pubill D, et al. Memantine is a useful drug to prevent the spatial and non-spatial memory deficits induced by methamphetamine in rats. Pharmacol Res 2010; 62(5): 450-6.
[44]
Xu BL, Wang R, Meng XH, et al. Effects of analog P165 of amyloid precursor protein 5-mer peptide on learning, memory and brain insulin receptors in the rat model of cognitive decline. Neurol Sci 2014; 35(11): 1821-6.
[45]
Nyitrai G, Spisák T, Spisák Z, et al. Stepwise occlusion of the carotid arteries of the rat: MRI assessment of the effect of donepezil and hypoperfusion-induced brain atrophy and white matter microstructural changes. PLoS One 2018; 13(5): e0198265.
[46]
Iwasaki Y, Ito S, Suzuki M, Nagahori T, Yamamoto T, Konno H. Forebrain ischemia induced by temporary bilateral common carotid occlusion in normotensive rats. J Neurol Sci 1989; 90(2): 155-65.
[47]
Farkas E, Luiten PG, Bari F. Permanent, bilateral common carotid artery occlusion in the rat: A model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 2007; 54(1): 162-80.
[48]
Lapi D, Vagnani S, Pignataro G, et al. Rat pialmicrovascular responses to transient bilateral common carotid artery occlusion and reperfusion: Quercetin’s mechanism of action. Front Physiol 2012; 3: 99.
[49]
Tiwari N, Bhatia P, Kumar A, Jaggi AS, Singh N. Potential of carnosine, a histamine precursor in rat model of bilateral common carotid artery occlusion-induced vascular dementia. Fundam Clin Pharmacol 2018; 32(5): 516-31.
[50]
Saxena A, Fedorko JM, Vinayaka C, et al. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases. Eur J Biochem 2003; 270(22): 4447-58.
[51]
Xiao Y, Guan ZZ, Wu CX, et al. Correlations between cholinesterase activity and cognitive scores in post-ischemic rats and patients with vascular dementia. Cell Mol Neurobiol 2012; 32(3): 399-407.
[52]
Tomimoto H, Ohtani R, Shibata M, et al. Loss of cholinergic pathways in vascular dementia of the Binswanger type. Dement Geriatr Cogn Disord 2005; 19(5-6): 282-8.
[53]
Liu K, Mori S, Takahashi HK, et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. The FASEB J 2007; 21(14): 3904-16.
[54]
Zhang R, Wang Y, Zhang L, et al. Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 2002; 33: 2675.
[55]
Singh N, Parle M. Sildenafil improves acquisition and retention of memory in mice. Indian J Physiol Pharmacol 2003; 47: 318-24.
[56]
Guzeloglu M, Yalcinkaya F, Atmaca S, et al. The beneficial effects of tadalafil on renal ischemia-reperfusion injury inrats. Urol Int 2011; 86: 197.
[57]
Rashid M, Kotwani A, Fahim M. Long-acting phosphodiesterase 5 inhibitor, tadalafil, and superoxide dismutasemimetic, tempol, protect against acute hypoxia-induced pulmonary hypertension in rats. Hum Exp Toxicol 2012; 31: 626.
[58]
Nunes AK, Raposo C, Luna RL, Cruz-Höfling MA, Peixoto CA. Sildenafil (Viagra) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model. Cytokine 2012; 60: 540.
[59]
Guazzi M, Samaja M. The role of PDE5-inhibitors in cardiopulmonary disorders: From basic evidence to clinical development. Curr Med Chem 2007; 14: 2181.
[60]
Bivalacqua TJ, Musicki B, Hsu LL, Berkowitz DE, Champion HC, Burnett AL. Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress. PLoS One 2013; 8: e68028.
[61]
Pelliccione F, D’Angeli A, D’Andrea S, et al. Tadalafil treatment had a modest effect on endothelial cell damage and repair ability markers in men with erectile dysfunction and vascular risk. Asian J Androl 2014; 16(2): 290-4.
Related Books
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research-Dementia
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Article Metrics
66
4
1
1